[Human papillomavirus (HPV) vaccines--a new method for the prevention of cervical cancer].
In the nearest future cervical cancer incidence may be significantly reduced thanks to specific antiviral vaccine use. In the paper we analyzed current literature concerning human papillomavirus (HPV) infection epidemiology and possibility of prophylactic and therapeutic vaccine use.
Friedek
Daniela A
DA
Z Katedry i Zakładu Mikrobiologii Lekarskiej Slaskiej Akademii Medycznej w Katowicach.
Ekiel
Alicja M
AM
Martirosian
Gayane
G
D000914:Antibodies, Viral / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology; D005260:Female; D006801:Humans; D015994:Incidence; D008403:Mass Screening; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000276:immunology / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000821:virology
D000914:Antibodies, Viral; D019496:Cancer Vaccines; D053918:Papillomavirus Vaccines